These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31471448)

  • 21. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.
    Quinlivan ML; Jensen NJ; Radford KW; Schmid DS
    J Clin Microbiol; 2012 May; 50(5):1533-8. PubMed ID: 22378912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral strain identification in varicella vaccinees with disseminated rashes.
    LaRussa P; Steinberg SP; Shapiro E; Vazquez M; Gershon AA
    Pediatr Infect Dis J; 2000 Nov; 19(11):1037-9. PubMed ID: 11099082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults.
    Macaladad N; Marcano T; Guzman M; Moya J; Jurado F; Thompson M; Meechan C; Li D; Schlienger K; Chan I; Sadoff J; Schödel F; Silber JL
    Vaccine; 2007 Mar; 25(11):2139-44. PubMed ID: 17250932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; McIntyre P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Parrino J; McNeil SA; Lawrence SJ; Kimby E; Pagnoni MF; Stek JE; Zhao Y; Chan IS; Kaplan SS
    Vaccine; 2017 Mar; 35(14):1764-1769. PubMed ID: 28268074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia's spontaneous vaccine pharmacovigilance system, 2016-2020.
    Li-Kim-Moy J; Phillips A; Morgan A; Glover C; Jayasinghe S; Hull BP; Dey A; Beard FH; Hickie M; Macartney K
    BMJ Open; 2023 Jan; 13(1):e067287. PubMed ID: 36707120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a skin- and neuro-attenuated live vaccine for varicella.
    Wang W; Pan D; Fu W; Ye X; Han J; Yang L; Jia J; Liu J; Zhu R; Zhang Y; Liu C; Ye J; Selariu A; Que Y; Zhao Q; Wu T; Li Y; Zhang J; Cheng T; Zhu H; Xia N
    Nat Commun; 2022 Feb; 13(1):824. PubMed ID: 35149692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella in pediatric patients.
    Drwal-Klein LA; O'Donovan CA
    Ann Pharmacother; 1993; 27(7-8):938-49. PubMed ID: 8395918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.
    Wang W; Pan D; Cheng T; Zhu H
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current status of live attenuated varicella vaccine.
    Gershon AA
    Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine Development for Varicella-Zoster Virus.
    Sadaoka T; Mori Y
    Adv Exp Med Biol; 2018; 1045():123-142. PubMed ID: 29896666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.